About us
ClinLife is a free and easy-to-use website helping patients worldwide find the most relevant clinical studies suitable to their medical condition. Listing all available studies by disease area or medical condition, it provides an essential link between research sites and people seeking clinical research studies.
Why did we start ClinLife?
ClinLife's initial purpose and the one that remains till this day, is to make it easier for patients around the world to find clinical research studies. Without clinical research, there would be no new medicines. ClinLife was driven by the following factors:
Minimizing delays
The lack of participants in clinical research: Up to 80% of the clinical research studies are delayed because of low patient recruitment. Recruitment challenges lead to delays in the availability of new medicines.
Increasing participation
Current research suggests that less than 10% of the public participates in clinical research studies.
Increasing awarenessLow participation rates in clinical research studies are often attributed to low awareness by patients and their physicians, as well as the fundamental lack of understanding of how clinical research is conducted and overseen by regulatory authorities.
High demand
Clinical research has an urgent need for patient volunteers as many new promising medicines for unmet needs in chronic, acute and rare disease continue to fill the drug development pipeline.
ClinLife Milestones
The first ClinLife study (type 2 diabetes) was conducted in 2005 in Berlin, Germany. Today, ClinLife is available in 50+ countries and 35+ languages and has successfully connected patients to more than 1,200 clinical trials.
2005 - ClinLife founded
2008 - 1 million ClinLife visitors per year
2015 - 500,000 registered ClinLife members worldwide
2018 - 1,000 clinical trials successfully supported
2021 - 1,200 clinical trials, and 1.4 million members and partnership with 100+ study centers in the USA alone
ClinLife is founded and operated by Clariness, an independent company based in Zurich, Switzerland, with subsidiaries in Germany, the USA, and the UK.